Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
AFFF Lawsuit Exposure to firefighting foam chemicals may result in an increased risk of cancer for firefighters, military and airport personnel.
Paraquat Parkinson’s Disease Lawsuits Exposure to the toxic herbicide Paraquat has been linked to a risk of Parkinson's disease.
Fosamax Jaw Cases To Be Remanded For Trials Nationwide at Fast Pace September 3, 2013 Austin Kirk Add Your Comments As the coordinated pretrial proceedings in the federal litigation over jaw necrosis from Fosamax comes to an end, the U.S. District Judge presiding over the cases has decided to begin remanding hundreds of lawsuits each month back to the courts where they originated, denying Merck’s attempts to drag out the proceedings and winding down the federal multidistrict litigation (MDL) even quicker than plaintiffs had proposed. Merck currently faces about 1,000 lawsuits in the federal court system involving plaintiffs who allege that they developed osteonecrosis of the jaw (ONJ) following Fosamax use, which involves a deterioration and decay of the jaw bone that is painful and often results in surgery to remove portions of the jaw. All of the complaints involves similar allegations that Merck failed to adequately warn consumers or the medical community about the potential side effects of Fosamax. Learn More About Fosamax Lawsuit Side effects of Fosamax linked to a risk of sudden femur fractures, severe jaw damage and other problems. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Fosamax Lawsuit Side effects of Fosamax linked to a risk of sudden femur fractures, severe jaw damage and other problems. Learn More SEE IF YOU QUALIFY FOR COMPENSATION The lawsuits have been centralized before U.S. District Judge John Keenan in the Southern District of New York since 2006, to reduce duplicative discovery, avoid conflicting pretrial rulings and to serve the convenience of witnesses, parties and the courts. Following mixed results from five “bellwether” trials held in the MDL, and a lack of progress towards a potential Fosamax settlement agreement, Judge Keenan has determined that the work in the MDL has concluded and all that remains is for each of the lawsuits to move forward with case-specific discovery and trial in the U.S. District Courts where they originally would have been filed. In an Order (PDF) issued August 29, Judge Keenan indicated that starting in November, 200 cases a month will be remanded back to U.S. District Courts nationwide for trial. Judge Keenan pointed out in the order that each of the Courts will have the benefit of the various opinions already issued in the litigation. Merck has attempted to delay the end of the MDL proceedings, failing to convince Judge Keenan to require hundreds of plaintiffs to submit additional documentation supporting their claim. Most recently, Merck proposed that Judge Keenan move forward with case-specific discovery on the 100 oldest cases as part of the MDL proceedings, before deciding what the best process is for remanding the cases. However, the Court has rejected this proposal as well. “[I]t does not seem prudent for case-specific discovery to proceed in this district, as it would unnecessarily prolong the MDL and introduce disputes that are more properly adjudicated in their home districts,” wrote Judge Keenan in the order. “Moreover, it is not clear how discovery on the first 100 cases will aid in the determination of the appropriate home districts for the remaining MDL docket.” Under Judge Keenan’s plan, the Fosamax jaw necrosis MDL could be concluded within the next six months. Unless a settlement is reached, the first order suggesting remand will be entered November 1, 2013. Once the litigation is spread out throughout the country, it will be substantially more difficult for Merck to negotiate any global resolution for the lawsuits. The drug maker will also face considerable pressure as hundreds of cases move toward trial simultaneously nationwide. However, the drug maker has refused to make settlement offers acceptable to plaintiffs in the cases, maintaining that they are confident in their ability to defend lawsuits at trial. Fosamax Bone Fracture Litigation Fosamax (alendronate sodium) is a blockbuster medication that was introduced by Merck in 1995, for treatment and prevention of osteoporosis. Before it became available as a generic in 2008, the medication generated over $3 billion in annual sales and was used by millions of Americans. In addition to lawsuits over jaw necrosis, Merck also faces hundreds of Fosamax femur fracture lawsuits filed by former users of the osteoporosis drug who allege that side effects of the medication caused them to suffer spontaneous broken bones that occurred following little or no trauma, such as falling from standing height or less. A second Fosamax MDL is pending in the District of New Jersey for all lawsuits involving bone fractures, with about 1,100 additional cases pending in that litigation. Merck also faces more than 2,800 lawsuits over Fosamax that are centralized in New Jersey state court, which is where the drug makers’ U.S. headquarters are based. Tags: Boniva, Femur Fracture, Fosamax, GlaxoSmithKline, Merck, ONJ, Osteonecrosis of the Jaw, Roche Image Credit: | More Fosamax Lawsuit Stories Fosamax Fracture Lawsuits Dismissed Again, After Judge Rules FDA Rejected Label Warning Change March 24, 2022 Zometa Side Effects Increase Risk of Osteonecrosis of the Jaw: Study January 14, 2021 Study Questions Whether Fosamax And Similar Bone Drugs Provide Benefits After Seven Years of Use December 10, 2020 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermCommentsThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Court Urged To Reject Motion To Dismiss Lawsuits Over Ozempic, Mounjaro Gastrointestinal Risks (Posted: today) Pushing back against a motion to dismiss, plaintiffs involved in GLP-1 lawsuits say GLP-1 manufacturers intentionally misled the medical community and patients regarding the safety of the diabetes and weight loss drugs. MORE ABOUT: OZEMPIC LAWSUITGLP-1 Manufacturers Argue Gastroparesis Lawsuits Should Require Contemporaneous Diagnostic Testing (03/17/2025)Study Suggests There May Not Be a Link Between Ozempic, Mounjaro and Post-Surgery Aspiration Pneumonia (03/12/2025)Ozempic Hair Loss Side Effects Doubled for Users, Study Finds (03/07/2025) McKesson Sterile Water Lawsuit Filed Against Amazon, Nurse Assist Over Bacterial Wound Infection (Posted: today) An Arizona man contends that the manufacturers delayed issuing a recall of sterile water products sold on Amazon, resulting in a serious infection requiring multiple surgeries. MORE ABOUT: STERILE SALINE SOLUTION RECALL LAWSUITSteriCare Sodium Chloride Lawsuit Claims Recalled Saline Solution Caused Infection, Wrongful Death (11/12/2024)Nurse Assist Sterile Water and Saline Recalled Following FDA “Do Not Use” Warning (11/07/2023) Hair Color Lawsuit Filed Over Salon Worker’s Bladder Cancer Diagnosis (Posted: yesterday) A hair dye cancer lawsuit filed by a New Jersey hairdresser claims she developed bladder cancer after 11 years of exposure. MORE ABOUT: HAIR DYE LAWSUITBrazilian Blowout Cancer Lawsuit Filed by Missouri Hair Stylists Over Exosure to Toxic Chemicals (03/11/2025)Initial Status Conference for Hair Dresser’s Bladder Cancer Lawsuit Set for May 5 (03/10/2025)Hair Stylists Bladder Cancer, Breast Cancer Risks Are Now Leading to Lawsuits Against Makers of Hair Coloring Products (02/24/2025)
Fosamax Fracture Lawsuits Dismissed Again, After Judge Rules FDA Rejected Label Warning Change March 24, 2022
Study Questions Whether Fosamax And Similar Bone Drugs Provide Benefits After Seven Years of Use December 10, 2020
Court Urged To Reject Motion To Dismiss Lawsuits Over Ozempic, Mounjaro Gastrointestinal Risks (Posted: today) Pushing back against a motion to dismiss, plaintiffs involved in GLP-1 lawsuits say GLP-1 manufacturers intentionally misled the medical community and patients regarding the safety of the diabetes and weight loss drugs. MORE ABOUT: OZEMPIC LAWSUITGLP-1 Manufacturers Argue Gastroparesis Lawsuits Should Require Contemporaneous Diagnostic Testing (03/17/2025)Study Suggests There May Not Be a Link Between Ozempic, Mounjaro and Post-Surgery Aspiration Pneumonia (03/12/2025)Ozempic Hair Loss Side Effects Doubled for Users, Study Finds (03/07/2025)
McKesson Sterile Water Lawsuit Filed Against Amazon, Nurse Assist Over Bacterial Wound Infection (Posted: today) An Arizona man contends that the manufacturers delayed issuing a recall of sterile water products sold on Amazon, resulting in a serious infection requiring multiple surgeries. MORE ABOUT: STERILE SALINE SOLUTION RECALL LAWSUITSteriCare Sodium Chloride Lawsuit Claims Recalled Saline Solution Caused Infection, Wrongful Death (11/12/2024)Nurse Assist Sterile Water and Saline Recalled Following FDA “Do Not Use” Warning (11/07/2023)
Hair Color Lawsuit Filed Over Salon Worker’s Bladder Cancer Diagnosis (Posted: yesterday) A hair dye cancer lawsuit filed by a New Jersey hairdresser claims she developed bladder cancer after 11 years of exposure. MORE ABOUT: HAIR DYE LAWSUITBrazilian Blowout Cancer Lawsuit Filed by Missouri Hair Stylists Over Exosure to Toxic Chemicals (03/11/2025)Initial Status Conference for Hair Dresser’s Bladder Cancer Lawsuit Set for May 5 (03/10/2025)Hair Stylists Bladder Cancer, Breast Cancer Risks Are Now Leading to Lawsuits Against Makers of Hair Coloring Products (02/24/2025)